Form 13-F position report

SUNSHINE BIOPHARMA INC

Reported by MORGAN STANLEY

SBFM CUSIP 867781403 Manager CIK 0000895421

Reported 0 shares, down 26 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-06-30 7000
2022-09-30 0
2023-03-31 19
2023-06-30 13
2023-09-30 8
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for SUNSHINE BIOPHARMA INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -26 (-100.0%) 0 $0 2024-02-13
Q3 2023 Unchanged 26 0 (0.0%) < 0.01% $8 2023-11-15
Q2 2023 Unchanged 26 0 (0.0%) < 0.01% $13 2023-08-14
Q1 2023 New 26 +26 (0.0%) < 0.01% $19 2023-05-15
Q3 2022 Reduced 0 -6,867 (-100.0%) 0 $0 2022-11-14
Q2 2022 New 6,867 +6,867 (0.0%) < 0.01% $7,000 2022-08-15

Who else reported the position

18 managers reported SUNSHINE BIOPHARMA INC for Q4 2023.

Managers reporting SUNSHINE BIOPHARMA INC in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARMISTICE CAPITAL LLC Added 2,130,000 +1,156,000 < 0.01% $578,295 3 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 286,100 0 < 0.01% $77,676 7 qtrs
CITADEL ADVISORS LLC New 185,255 +185,255 < 0.01% $50,297 1 qtr
RENAISSANCE TECHNOLOGIES LLC New 66,600 +66,600 < 0.01% $18,000 1 qtr
Virtu Financial LLC New 23,862 +23,862 < 0.01% $6,000 1 qtr
GEODE CAPITAL MANAGEMENT LLC Unchanged 20,179 0 < 0.01% $5,478 8 qtrs
XTX Topco Ltd New 17,495 +17,495 < 0.01% $4,750 1 qtr
Bank of America Corporation New 10,000 +10,000 < 0.01% $2,710 1 qtr
NATIONAL BANK OF CANADA FI Unchanged 6,042 0 < 0.01% $1,631 5 qtrs
UBS Group AG Added 2,201 +2,200 < 0.01% $598 8 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 13, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.